Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc. Harvard Case Solution & Analysis

The global pharmaceutical industry has experienced significant changes in the past few decades, pharmaceutical companies face significant challenges, including headlines trials imminent expiration of patents, new technologies, rising drug development, the total replacement therapy, international competition, and the complex state policy issues. Describes the pharmaceutical industry in 2006, including: the process of drug development, biotechnology and the threat of generic competition; pharmaceutical manufacturing, sales and marketing, as well as drug use in Europe, the Third World, and the U.S. Merck and Pfizer are analyzed in-depth and contrast between Merck, a research firm unlike mergers and Pfizer, as the marketing power grows through acquisitions, developing. Thirteen pieces give specific attention to the case. "Hide
by David J. Collis, Troy Smith Source: Harvard Business School 37 pages. Publication Date: November 27, 2006. Prod. #: 707509-PDF-ENG

Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc. Case Solution Other Similar Case Solutions like

Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc.

Share This